These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9746675)

  • 1. Breast Cancer Screening For Women Ages 40-49--NIH Consensus Statement.
    Medscape Womens Health; 1997 Feb; 2(2):1. PubMed ID: 9746675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH Consensus Statement on Breast Cancer Screening for Women in Their 40s: How Will It Affect Patient Care?
    Huey FL
    Medscape Womens Health; 1997 Apr; 2(4):1. PubMed ID: 9746688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
    NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Another round in the mammography controversy.
    Meissner HI; Rimer BK; Davis WW; Eisner EJ; Siegler IC
    J Womens Health (Larchmt); 2003 Apr; 12(3):261-76. PubMed ID: 12804357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey.
    Sabatino SA; Burns RB; Davis RB; Phillips RS; Chen YH; McCarthy EP
    Cancer; 2004 Jun; 100(11):2338-46. PubMed ID: 15160336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer in pre-menopausal women. Who should decide?
    Berrino F; Bouchardy C; Sasco AJ
    Int J Cancer; 1995 Jan; 60(2):153-5. PubMed ID: 7829231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the knowledge of women and registered nurses in Japan regarding the benefits and risks of breast cancer screening.
    Shimada T; Takahashi M; Shimizu Y; Hashimoto M
    J Rural Med; 2017 Nov; 12(2):98-104. PubMed ID: 29255526
    [No Abstract]   [Full Text] [Related]  

  • 19. Each woman should decide for herself (the controversy and confusion about mammography for women in their 40s continues....).
    Richards MJ
    Wis Med J; 1997 Apr; 96(4):6-7. PubMed ID: 9128426
    [No Abstract]   [Full Text] [Related]  

  • 20. The canadian national breast screening study: why it deserves support.
    Baines CJ; Miller AB
    Can Fam Physician; 1982 Mar; 28():481-5. PubMed ID: 21286076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.